{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0009823/OMIM:259900","label":"Hyperoxaluria, primary, type I","mondoId":"MONDO:0009823","onsetQualifier":null,"recordKeys":["054900db6436cd10c935486ef3df88287fa0a978d386bfd20c8ae71ca1ab174d","07af6f00904a261712fcde80c2103eeee0baf8f8aa4ef501201429a4cb810b09","0ee4816ffc07ff368cc4c246b15ed1584a775f2c60fa8d8616bfac3f25e47569","1e62f7397bd9dcc044d8a807abae482d7bc68101763a7e47d462c3c039cacd21","39ef4fc0468c290acf363b10bd0fc8cd71bebac286c1038c7292cfa070eb8773","41c4033310c5c5b17009973bf0c2c4e536ec28b397b4eb4b159905df88fdf256","5482e2946aa410ffae8b12c6416dacab0aa1f65200d183a3f39f3b96d75ea285","5cd6562400518022108d9070cee1d4c9958e4d5518a348ce0bc66dabe463b198","67a866e72944b963e62a2fc0717197009c6508344d1505e707a500738e029e07","80ba6148cba3ed9c0a39a5e529a0b497bd90cc65fd32c9b9929754e0e0c4047c","94097ce1b89b89019ab09ec423819e9da27ea08cfcf56476eb78c56f8e3e38de","9a32a06948e0f9158aa6b30c4d22841b15c483eab6bcb8956fb38e2333995349","9c7743e0ad239784bf7dff7f5579d29ecb8329ff587808268aac6ad3cd8c94fe","ab79f110d18c2e722e1f2a6f1776c220bc1dd5f807ecdb9bbdb67a40cd1f3bc8","c94d7200dd54fcc293965121dfb1613de325a39b40797dfc2be8541360b9e88d","ccf55bc357db621ab9e761d8f5aa511ac18a44d63ed0c8661228ef9f218a01bf","cfaa1e7f3da8f46d5155ab7884acde746c1fb3fb341f4997241244f7d35d3ec2","d3c909b0dbe58e880bed7f6808297de19ade9c70b22a383faa787e55cf853696","d3db3b8e946bb368b403c3e1a655a1589befd49c1c620212767e6ddeacce38c9","d3ee045c75afcee13dd1b0676171034e8dd29cb5dd804e1f05813049e142b9a9","d7f11fb7a8e737c6589b066b5ab7d8e5735fbedef3768932b18c183a287f82a9","da2e0544db03cc3f4d4b0eebab26303d2e068ce298f1270247b25e7f36e14651","e25e722c40fefe8c70b05725c64f70acceb0508489c3f0a9c4c9bb62b639a317","e509a7adb7216565fac334d760d939876a400933c4f29d91f6a137d1161551f3","e837a9340b2583e869505a0dbd8725eed04c0d8bf2b26defe0df66a65af39893","ea952d01b08fcf2bf9bac8e9b40da2692ec425b37cf72531715daaa6f8e75568","edf6f03dd51a8a850b0a92b88a37885ef0f132713d1000b7a9c5742f8ca8310e","eeadf09b54ef2493d1140a56b660ceb168f10d0cc7ce746f1a47a7123be977cf"],"recordQualifiers":{},"scopeLabel":"OMIM:259900","sourceIds":["OMIM:259900"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"MONDO:0009823/ORPHA:93598","label":"Primary hyperoxaluria type 1","mondoId":"MONDO:0009823","onsetQualifier":null,"recordKeys":["23aba4817b7b2a1bb073c7515da2e09c6d04778c9d635c4f492a596528d2215d","3a0f00099324a590e33d3dbdcbc21e73bc2479dec910b90db010731ffbcbfd45","4d4044a3ba47aba89d64f8d3cd87f6f98cc4b4cd97a4af8740124c19aa9ca135","4d6cea65fdb43ea4570103186e5ead118c565d81a5e032d9379d7137064b2171","4f8a154ee605a97085b3d150d3a7a814af1321173fce70e69af64d6c524e9d64","5936aa488f9fed457e56aa3004875c972fe721c756e98bb8895a064a0dd53c46","5c9f7257faac96eaffe0351e9461f3698fa95df9dc2357085735e6c232f7a304","678188c53461305c1af87c432fcd12fb98562207f784f4c4c8ecbcbc59a930c8","75628f5bc7bcae99e72a882046e6de45aaf98934c3cb02459b616a3334bf06fc","77a4e41c312866a5f6645517a9024ae0e5969efe8176643260235d549cb024f5","8a3fb56b34ed61c50033d41f4358d2ff13df9815d4187aa8bbf82f5f0d48dae5","938f83c8d28a370baac39bae1bc815c7436f2eebad2bf1bca10a828939509125","a37d1e2e85f4e0d9f255e13c6cc888525baea20b939da68635f114b4bfb520a3","bcf4ff6d9d6189ae5af4d4f02be527d876f9c198d657d4734f94829f139a32f6","d78fe3b713672c7971b030801e5e3072bbfa180f4915b613f91c3de773f5b477","daa42829d012fd35ba4d3c7bbaec04dc283c9abc21addac74d19e72b1a60bb43","e46f6286d15916ab71916c327bd692f08b32d33f4a8998de334ee5d1cf47019d","f9c1ab898489b8d994eb1652606496e6724b26efd850e1056a0243483216b2e5","fac1aa3ad7b4a11d6fa545c2cb7a9d19b0aed29795edcc9c27d93618f313b746"],"recordQualifiers":{},"scopeLabel":"ORPHA:93598","sourceIds":["ORPHA:93598"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0009823/OMIM:259900","MONDO:0009823/ORPHA:93598"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":6,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":47,"sourceGroups":{"omim":20,"orphanet":19,"published":8}},"features":[{"hpoId":"HP:0011021","label":"Abnormal circulating enzyme concentration","primary":false},{"hpoId":"HP:0001939","label":"Abnormality of metabolism/homeostasis","primary":false},{"hpoId":"HP:0000164","label":"Abnormality of the dentition","primary":false},{"hpoId":"HP:0000924","label":"Abnormality of the skeletal system","primary":false},{"hpoId":"HP:0001063","label":"Acrocyanosis","primary":false},{"hpoId":"HP:0001903","label":"Anemia","primary":false},{"hpoId":"HP:0025324","label":"Arterial occlusion","primary":false},{"hpoId":"HP:0002621","label":"Atherosclerosis","primary":false},{"hpoId":"HP:0001678","label":"Atrioventricular block","primary":false},{"hpoId":"HP:0002653","label":"Bone pain","primary":false},{"hpoId":"HP:0003761","label":"Calcinosis","primary":false},{"hpoId":"HP:0025520","label":"Calcinosis cutis","primary":false},{"hpoId":"HP:0008672","label":"Calcium oxalate nephrolithiasis","primary":false},{"hpoId":"HP:0011506","label":"Choroidal neovascularization","primary":false},{"hpoId":"HP:0000965","label":"Cutis marmorata","primary":false},{"hpoId":"HP:0012213","label":"Decreased glomerular filtration rate","primary":false},{"hpoId":"HP:0001944","label":"Dehydration","primary":false},{"hpoId":"HP:0100518","label":"Dysuria","primary":false},{"hpoId":"HP:6000431","label":"Elevated urinary glycolic acid level","primary":false},{"hpoId":"HP:6000702","label":"Elevated urinary glyoxylic acid level","primary":false},{"hpoId":"HP:0000805","label":"Enuresis","primary":false},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":false},{"hpoId":"HP:0100758","label":"Gangrene","primary":false},{"hpoId":"HP:0000790","label":"Hematuria","primary":false},{"hpoId":"HP:0003159","label":"Hyperoxaluria","primary":false},{"hpoId":"HP:0011001","label":"Increased bone mineral density","primary":false},{"hpoId":"HP:0004417","label":"Intermittent claudication","primary":false},{"hpoId":"HP:0000787","label":"Kidney stone","primary":false},{"hpoId":"HP:0001942","label":"Metabolic acidosis","primary":false},{"hpoId":"HP:0000121","label":"Nephrocalcinosis","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0001138","label":"Optic neuropathy","primary":false},{"hpoId":"HP:0002756","label":"Pathologic fracture","primary":false},{"hpoId":"HP:0004950","label":"Peripheral arterial stenosis","primary":false},{"hpoId":"HP:0009830","label":"Peripheral neuropathy","primary":false},{"hpoId":"HP:0030880","label":"Raynaud phenomenon","primary":false},{"hpoId":"HP:0000010","label":"Recurrent urinary tract infections","primary":false},{"hpoId":"HP:0035005","label":"Reduced hepatic alanine-glyoxylate aminotransferase activity","primary":false},{"hpoId":"HP:0000083","label":"Renal insufficiency","primary":false},{"hpoId":"HP:0030507","label":"Retinal crystals","primary":false},{"hpoId":"HP:0000488","label":"Retinopathy","primary":false},{"hpoId":"HP:0003774","label":"Stage 5 chronic kidney disease","primary":false},{"hpoId":"HP:0001297","label":"Stroke","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0009823","records":[{"frequencyKind":"count","key":"054900db6436cd10c935486ef3df88287fa0a978d386bfd20c8ae71ca1ab174d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001944","is_excluded":false,"label":"Dehydration","onset_id":null,"reference":"PMID:9643991","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"07af6f00904a261712fcde80c2103eeee0baf8f8aa4ef501201429a4cb810b09","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0035005","is_excluded":false,"label":"Reduced hepatic alanine-glyoxylate aminotransferase activity","onset_id":null,"reference":"PMID:2880111","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"0ee4816ffc07ff368cc4c246b15ed1584a775f2c60fa8d8616bfac3f25e47569","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001942","is_excluded":false,"label":"Metabolic acidosis","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"1e62f7397bd9dcc044d8a807abae482d7bc68101763a7e47d462c3c039cacd21","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000121","is_excluded":false,"label":"Nephrocalcinosis","onset_id":null,"reference":"PMID:9643991","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"23aba4817b7b2a1bb073c7515da2e09c6d04778c9d635c4f492a596528d2215d","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012213","is_excluded":false,"label":"Decreased glomerular filtration rate","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"39ef4fc0468c290acf363b10bd0fc8cd71bebac286c1038c7292cfa070eb8773","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0004417","is_excluded":false,"label":"Intermittent claudication","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"3a0f00099324a590e33d3dbdcbc21e73bc2479dec910b90db010731ffbcbfd45","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0000164","is_excluded":false,"label":"Abnormality of the dentition","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"41c4033310c5c5b17009973bf0c2c4e536ec28b397b4eb4b159905df88fdf256","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002756","is_excluded":false,"label":"Pathologic fracture","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"4d4044a3ba47aba89d64f8d3cd87f6f98cc4b4cd97a4af8740124c19aa9ca135","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000790","is_excluded":false,"label":"Hematuria","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4d6cea65fdb43ea4570103186e5ead118c565d81a5e032d9379d7137064b2171","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0001297","is_excluded":false,"label":"Stroke","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4f8a154ee605a97085b3d150d3a7a814af1321173fce70e69af64d6c524e9d64","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003761","is_excluded":false,"label":"Calcinosis","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"5482e2946aa410ffae8b12c6416dacab0aa1f65200d183a3f39f3b96d75ea285","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0009830","is_excluded":false,"label":"Peripheral neuropathy","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"5936aa488f9fed457e56aa3004875c972fe721c756e98bb8895a064a0dd53c46","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5c9f7257faac96eaffe0351e9461f3698fa95df9dc2357085735e6c232f7a304","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100518","is_excluded":false,"label":"Dysuria","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"5cd6562400518022108d9070cee1d4c9958e4d5518a348ce0bc66dabe463b198","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001138","is_excluded":false,"label":"Optic neuropathy","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"678188c53461305c1af87c432fcd12fb98562207f784f4c4c8ecbcbc59a930c8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011021","is_excluded":false,"label":"Abnormal circulating enzyme concentration","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"67a866e72944b963e62a2fc0717197009c6508344d1505e707a500738e029e07","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0030507","is_excluded":false,"label":"Retinal crystals","onset_id":null,"reference":"PMID:23666469","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"75628f5bc7bcae99e72a882046e6de45aaf98934c3cb02459b616a3334bf06fc","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000010","is_excluded":false,"label":"Recurrent urinary tract infections","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"77a4e41c312866a5f6645517a9024ae0e5969efe8176643260235d549cb024f5","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000805","is_excluded":false,"label":"Enuresis","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"80ba6148cba3ed9c0a39a5e529a0b497bd90cc65fd32c9b9929754e0e0c4047c","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001063","is_excluded":false,"label":"Acrocyanosis","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"8a3fb56b34ed61c50033d41f4358d2ff13df9815d4187aa8bbf82f5f0d48dae5","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000787","is_excluded":false,"label":"Kidney stone","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"938f83c8d28a370baac39bae1bc815c7436f2eebad2bf1bca10a828939509125","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003159","is_excluded":false,"label":"Hyperoxaluria","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"94097ce1b89b89019ab09ec423819e9da27ea08cfcf56476eb78c56f8e3e38de","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001678","is_excluded":false,"label":"Atrioventricular block","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"9a32a06948e0f9158aa6b30c4d22841b15c483eab6bcb8956fb38e2333995349","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002653","is_excluded":false,"label":"Bone pain","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"9c7743e0ad239784bf7dff7f5579d29ecb8329ff587808268aac6ad3cd8c94fe","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0003159","is_excluded":false,"label":"Hyperoxaluria","onset_id":null,"reference":"PMID:9643991","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"a37d1e2e85f4e0d9f255e13c6cc888525baea20b939da68635f114b4bfb520a3","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001942","is_excluded":false,"label":"Metabolic acidosis","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"ab79f110d18c2e722e1f2a6f1776c220bc1dd5f807ecdb9bbdb67a40cd1f3bc8","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000965","is_excluded":false,"label":"Cutis marmorata","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"bcf4ff6d9d6189ae5af4d4f02be527d876f9c198d657d4734f94829f139a32f6","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0002621","is_excluded":false,"label":"Atherosclerosis","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"c94d7200dd54fcc293965121dfb1613de325a39b40797dfc2be8541360b9e88d","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000488","is_excluded":false,"label":"Retinopathy","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ccf55bc357db621ab9e761d8f5aa511ac18a44d63ed0c8661228ef9f218a01bf","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0004950","is_excluded":false,"label":"Peripheral arterial stenosis","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"cfaa1e7f3da8f46d5155ab7884acde746c1fb3fb341f4997241244f7d35d3ec2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0011001","is_excluded":false,"label":"Increased bone mineral density","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"d3c909b0dbe58e880bed7f6808297de19ade9c70b22a383faa787e55cf853696","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0025324","is_excluded":false,"label":"Arterial occlusion","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"d3db3b8e946bb368b403c3e1a655a1589befd49c1c620212767e6ddeacce38c9","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:6000431","is_excluded":false,"label":"Elevated urinary glycolic acid level","onset_id":null,"reference":"PMID:4701948","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"d3ee045c75afcee13dd1b0676171034e8dd29cb5dd804e1f05813049e142b9a9","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000790","is_excluded":false,"label":"Hematuria","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"d78fe3b713672c7971b030801e5e3072bbfa180f4915b613f91c3de773f5b477","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000121","is_excluded":false,"label":"Nephrocalcinosis","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"d7f11fb7a8e737c6589b066b5ab7d8e5735fbedef3768932b18c183a287f82a9","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000083","is_excluded":false,"label":"Renal insufficiency","onset_id":null,"reference":"PMID:9643991","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"da2e0544db03cc3f4d4b0eebab26303d2e068ce298f1270247b25e7f36e14651","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0025520","is_excluded":false,"label":"Calcinosis cutis","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"daa42829d012fd35ba4d3c7bbaec04dc283c9abc21addac74d19e72b1a60bb43","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003774","is_excluded":false,"label":"Stage 5 chronic kidney disease","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e25e722c40fefe8c70b05725c64f70acceb0508489c3f0a9c4c9bb62b639a317","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0011506","is_excluded":false,"label":"Choroidal neovascularization","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"e46f6286d15916ab71916c327bd692f08b32d33f4a8998de334ee5d1cf47019d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0001939","is_excluded":false,"label":"Abnormality of metabolism/homeostasis","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e509a7adb7216565fac334d760d939876a400933c4f29d91f6a137d1161551f3","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0008672","is_excluded":false,"label":"Calcium oxalate nephrolithiasis","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"e837a9340b2583e869505a0dbd8725eed04c0d8bf2b26defe0df66a65af39893","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0030880","is_excluded":false,"label":"Raynaud phenomenon","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ea952d01b08fcf2bf9bac8e9b40da2692ec425b37cf72531715daaa6f8e75568","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0100758","is_excluded":false,"label":"Gangrene","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"edf6f03dd51a8a850b0a92b88a37885ef0f132713d1000b7a9c5742f8ca8310e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:6000702","is_excluded":false,"label":"Elevated urinary glyoxylic acid level","onset_id":null,"reference":"PMID:449695","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"eeadf09b54ef2493d1140a56b660ceb168f10d0cc7ce746f1a47a7123be977cf","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:259900","disease_name":"Hyperoxaluria, primary, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"OMIM:259900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"f9c1ab898489b8d994eb1652606496e6724b26efd850e1056a0243483216b2e5","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001903","is_excluded":false,"label":"Anemia","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fac1aa3ad7b4a11d6fa545c2cb7a9d19b0aed29795edcc9c27d93618f313b746","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:93598","disease_name":"Primary hyperoxaluria type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000924","is_excluded":false,"label":"Abnormality of the skeletal system","onset_id":null,"reference":"ORPHA:93598","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"primary-hyperoxaluria-type-1","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"primary hyperoxaluria type 1"},"schemaVersion":1}